Chapter·PharmacologyPharmacogenomics

Pharmacogenomics in Cardiovascular TherapeuticsDownloads

10Questions
8Flashcards
1Tables & Flowcharts

Study Materials

Practice

Sample Questions

1

Which among the following is the false statement regarding statins?

AThese drugs should not be stopped even in severe conditions like injury, surgery etc.

BAlthough HMG-CoA reductase inhibitors substantially reduce the risk of cardiovascular events, there is mild increase in lipoprotein a (Lpa) levels.

CWith the long term use, there is slight increase in the incidence of type 2 diabetes mellitus.

DThey can be given with verapamil and other enzyme inhibitors

2

Which of the following is a characteristic of simvastatin?

ASpecific CYP3A4 substrate with high interaction potential

BDerived from fungal metabolite

CProdrug requiring hepatic activation

DShort half-life requiring evening dosing

3

Which of the following is not considered a pharmacogenetic condition?

AAdenosine deaminase deficiency

BCoumarin insensitivity

CG6PD deficiency

DMalignant hyperthermia

+ 7 more in the PDF

More Pharmacogenomics downloads

Browse all chapters

View all